Reduction of elevated total and LDL-C levels in patients with primary hypercholesterolemia, when the response to diet and other nonpharmacological measure alone has been inadequate.
Reducing elevated LDL-C levels in patients with combined hypercholesterolemia and hypertriglyceridemia where hypercholesterolemia is the major abnormality (Type IIb hyperlipoproteinemia).
Other Services
Country
Account